To address conflicting reports about the cardiovascular safety of DPP-4 inhibitors, researchers performed a large retrospective cohort study.
Impact of Ethnicity, Gender on Skin Autoflourescence and Risk for CV, DM
A new study evaluates the impact of ethnicity on skin autoflourescence used to measure accumulation of atherogenic glycated proteins.
The Revised Cholesterol Guidelines
What about those patients who fall into the "gray zone"?
The Artificial Sweetener Paradox: Weight Gain and Metabolic Dysfunction?
A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.
Stress Reduction Lowers Glucose Levels in Obese Women
Mindfulness: a potential intervention for T2DM?
Quiz: The 2017 AACE/ACE Lipid Management and CVD Prevention Guidelines
The 2017 lipid management guidelines have met both accolades and controversy. Take our quick quiz on the updates.
Beta Blockers Heighten Risk of CV Events in T2DM
Post-hoc analysis of ACCORD trial data suggests the indication of beta blocker therapy in T2DM patients be more closely examined.
Diabetes News Roundup: New Thoughts on Standard Thinking
Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.
Processed Meats Top List of Foods Linked to CHD and Diabetes
How much of which foods truly promote cardiometabolic health? First-of-its-kind study quantifies impact of good food and bad.
Vitamin D Status & Cardiovascular Disease Risk
Three studies examined the relationship between CVD risk and vitamin D status in children, adolescents, and women.
Interesting T2DM: FDA News & Diabetes Risk
Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.